최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한방사선종양학회지 = The Journal of the Korean soceity for therapeutic radiology and oncology, v.24 no.2, 2006년, pp.110 - 115
기용간 (부산대학교 의과대학 방사선종양학교실) , 권병현 (부산대학교 의과대학 방사선종양학교실) , 김원택 (부산대학교 의과대학 방사선종양학교실) , 남지호 (부산대학교 의과대학 방사선종양학교실) , 윤만수 (부산대학교 의과대학 산부인과학교실) , 이형식 (동아대학교 의과대학 방사선종양학교실) , 김동원 (부산대학교 의과대학 방사선종양학교실)
Purpose: This study was performed to determine the prognostic factors influencing relapse pattern, overall and disease-free survival in patients treated with postoperative radiotherapy for endometrial carcinoma. Materials and Methods: The records of 54 patients with endometrial adenocarcinoma treate...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Jemal A, Murray T, Samuels A, et al. Cancer statics, 2004. CA Cancer J Clin 2004;54:8-29
Ministry of Health and Welfare, R.O.K. 2002 Annual Report of the Korea Central Cancer Registry 2003
Berek JS, Haker NF. Practical gynecologic oncology. 3rd ed. Philadelphia; Lippincott Williams, Wilkins, 2000:407-455
Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 2006;24: 36-44
Zanio RJ, Kurman RJ, Diana KL, Morrow CP. Pathologic models to predict outcome for women with endometrial adenocarcinoma. Cancer 1996;77:1115-1121
Amant F, Cadron I, Fuso L, et al. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol Oncol 2005;98:274-280
Scholten AN, Cresutzberg CL, Noordijk EM, Smit VT. Long-term outcome in endometrial carcinoma favors a two-instead of a three-tiered grading system. Int J Radiat Oncol Biol Phys 2002;52:1067-1074
Briet JM, Hollema H, Reesink N, et al. Lymphovascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 2005;96:799-804
Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium. Gyecol Oncol 1991;40:55-65
Lurain JR, Rice BL, Rademaker AW, Proggensee LE, Schink JC, Miller DS. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1991;78:63-69
Jereczek-fossa B, Badzio A, Jassem J. Surgery followed by radiotherapy in endometrial cancer: analysis of survival and pattern of failure. Int J Gynecol Cancer 1999;9:285-294
Descamps P, Calais G, Moire C, et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol Oncol 1997;64:54-58
Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma. Gynecol Oncol 2004;94:241-242
Aalders JG, vd Syde R, Poppema S, Szabo BG, Janssens J. Prognostic factors and changing trends in the treatment of Stage I endometrial cancer: a clinical and histopathological study of 182 patients. Int J Radiat Oncol Biol Phys 1984;10: 2083-2088
Kuten A, Grigsby PW, Perez CA, Fineberg B, Garcia DM, Simpson JR. Results of radiotherapy in recurrent endometrial carcinoma: a retrospective analysis of 51 patients. Int J Radiat Oncol Biol Phys 1989;17:29-34
Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, et al. Outcome of high risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol 2004;22:1234-1241
Thigpen JT, Brady MF, Homesley HD, et al. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 2004;22:3902-3908
Thigpen JT, Brady MF, Alvarez RD, et al. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the gynecologic oncologic group. J Clin Oncol 1999;17:1736- 1744
Lentz SS, Brady MF, Major FJ, Redi GC, Soper JT. Highdose megesterol acetate in advanced or recurrent endometrial carcinoma: a gynecologic oncologic group study. J Clin Oncol 2004;14:357-361
※ AI-Helper는 부적절한 답변을 할 수 있습니다.